Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
News-Danish pharmaceuticals cancel agreement...PD drug
Neurosearchsays sees DKK 85 mln 99 loss
COPENHAGEN, June 29 (Reuters) - Danish pharmaceuticals firm
Neurosearch said on Tuesday it had agreed with Bristol-Myers Squibb
(NYSE:BMY - news) to cancel their agreement on the joint development of
Neurosearch"s anti-Parkinsons disease drug Brasofine. <snip>
--
Judith Richards, London, Ontario, Canada
<judithr@xxxxxxxx>
^^^
\ /
\ | / Today?s Research
\\ | // ...Tomorrow?s Cure
\ | /
\|/
```````
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance